info iconCurrently, the share price for Aurobindo Pharma Ltd. is delayed.

close icon
Aurobindo Pharma Ltd. Logo

Aurobindo Pharma Ltd.

--   ( -- %) 1D

  • Prev. Close
  • Upper Circuit
  • Lower Circuit

Analyst Sentiment For Aurobindo Pharma Ltd.

Info icon
As recommended by 27 analysts


Aurobindo Pharma Ltd.'s Info & Management

Founded in 1986, Aurobindo Pharma Limited operates as a pharmaceutical company with its headquarters in Hyderabad, India. The company’s primary focus is on the manufacturing and marketing of active pharmaceutical ingredients, branded pharmaceuticals, generic pharmaceuticals, and associated services.

Business Segment

The business operation includes:

  • Product Portfolio: covers seven therapeutic areas Central Nervous Systems (CNS), Antiretrovirals (ARVs), Cardiovascular (CVS), Semi-Synthetic Penicillin (SSP) – Orals & Sterile, Anti-infectives, Anti-diabetics, and Cephalosporins – Orals
  • Manufacturing Facilities: are located both within and outside India 

Geographical Presence

Geographically, its operational scope spans India, the USA, Europe, and the Rest of the World. 

  • Company Secretary
    B Adi Reddy
  • Chief Financial Officer
    Mr. Santhanam Subramanian

FAQs on Aurobindo Pharma Ltd.

What is the share price of Aurobindo Pharma Ltd.?

Aurobindo Pharma Ltd. share price is ₹1,326.85 as of July 12, 2024, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

What is the 52-week high and low of Aurobindo Pharma Ltd.?

The 52-week high and low of Aurobindo Pharma Ltd. is ₹1,344.20 and ₹720.80 respectively as of July 12, 2024, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

What are the Upper Circuit and Lower Circuit of Aurobindo Pharma Ltd.?

The Upper Circuit of Aurobindo Pharma Ltd. is ₹1,450. The Lower Circuit of Aurobindo Pharma Ltd. is ₹1,186.

What is the ROE of Aurobindo Pharma Ltd.?

Aurobindo Pharma Ltd. reported an ROE of 11.20% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of Aurobindo Pharma Ltd.?

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Aurobindo Pharma Ltd., Promoter held 51.8%, the FII held 16.7%, DII held 24.8% and the public held 6.7% of the total shares.

How to buy Aurobindo Pharma Ltd. Share?

You can easily buy shares of Aurobindo Pharma Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of Aurobindo Pharma Ltd.?

The fair value of Aurobindo Pharma Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer